Pharmacokinetics and Pharmacodynamics of Cenerimod, A Selective S1P(1)R Modulator, Are Not Affected by Ethnicity in Healthy Asian and White Subjects

Cenerimod is a sphingosine‐1‐phosphate 1 receptor (S1P(1)R) modulator in phase II development for treatment of systemic lupus erythematosus. Its pharmacokinetics (PKs), pharmacodynamics (PDs), as well as safety and tolerability were investigated in white and Asian subjects to allow for recruitment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Juif, Pierre‐Eric, Dingemanse, Jasper, Winkle, Peter, Ufer, Mike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877840/
https://www.ncbi.nlm.nih.gov/pubmed/32860737
http://dx.doi.org/10.1111/cts.12873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877840/
https://www.ncbi.nlm.nih.gov/pubmed/32860737
http://dx.doi.org/10.1111/cts.12873

Ejemplares similares